An induced pluripotent stem cell line derived from a patient with neonatal diabetes and Fanconi-Bickel syndrome caused by a homozygous mutation in the SLC2A2 gene
Publication date: Available online 21 June 2021Source: Stem Cell ResearchAuthor(s): Ahmed K. Elsayed, Sara Al-Khawaga, Khalid Hussain, Essam M. Abdelalim
Source: Stem Cell Research - Category: Stem Cells Source Type: research
More News: Diabetes | Endocrinology | Genetics | Perinatology & Neonatology | Stem Cell Therapy | Stem Cells